
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
Author(s) -
Aria Vaishnavi,
Joseph Juan,
Maebh Jacob,
Christopher M. Stehn,
Eric E. Gardner,
Michael T. Scherzer,
Sophia Schuman,
J. Edward Van Veen,
Brandon Murphy,
Christopher S. Hackett,
Adam J. Dupuy,
Steven A. Chmura,
Louise van der Weyden,
Justin Y. Newberg,
Annie Liu,
Karen Mann,
Alistair G. Rust,
William A. Weiss,
Conan G. Kinsey,
David J. Adams,
Allie H. Grossmann,
Michael B. Mann,
Martin McMahon
Publication year - 2022
Publication title -
cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.103
H-Index - 449
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/0008-5472.can-21-3214
Subject(s) - cancer research , biology , wnt signaling pathway , carcinogenesis , gene silencing , axin2 , lung cancer , tumor progression , cancer , pathology , gene , genetics , medicine